On 21 May, Weibo Corp (ADR) (NASDAQ:WB) announced its unaudited financial results for the first quarter ended March 31, 2014. Net revenues increased 161% year over year to $67.5 million. Advertising and marketing revenues grew 176% year over year to $51.9 million. Weibo Value Added Services (“Weibo VAS”) revenues increased 120% year over year to $15.7 million. Net loss increased 146% year over year to $47.4 million, or $0.31 diluted net loss per share attributable to Weibo’s ordinary shareholders. Weibo Corp (ADR) (NASDAQ:WB) net profit margin is -74.70% and weekly performance is 2.23%. On last trading day company shares ended up $18.78. Analysts mean target price for the company is $25.00. Weibo Corp (ADR) (NASDAQ:WB) distance from 50-day simple moving average (SMA50) is -2.86%.
On 27 May Pfizer Inc. (NYSE:PFE) announced that it has abandoned its efforts to acquire London-based AstraZeneca plc (NYSE:AZN) for $117 billion after a BST deadline, the official deadline for the latter company to make a decision, expired. Pfizer Inc. (NYSE:PFE) shares advanced 0.17% in last trading session and ended the day on $29.64. PFE Gross Margin is 81.90% and its return on assets is 23.50%. Pfizer Inc. (NYSE:PFE) quarterly performance is -8.69%.
Merck & Co., Inc. (NYSE:MRK) declared that the highly anticipated immunotherapy proved its usefulness on the patients diagnosed with lung cancer, neck or head cancer and advanced melanoma. Merck & Co., Inc. (NYSE:MRK) shares moved up 0.03% in last trading session and was closed at $57.93, while trading in range of $57.51 – $58.01. Merck & Co., Inc. (NYSE:MRK) year to date (YTD) performance is 16.65%.
On 19 May AstraZeneca plc (ADR) (NYSE:AZ) reported $1.17 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.23 by $0.06. The company had revenue of $6.42 billion for the quarter, compared to the consensus estimate of $6.32 billion. During the same quarter last year, the company posted $1.41 earnings per share. AstraZeneca plc (ADR)’s revenue was up .5% compared to the same quarter last year. Analysts expect that AstraZeneca plc will post $4.23 EPS for the current fiscal year. AstraZeneca plc (ADR) (NYSE:AZ) ended the last trading day at $72.65. Company weekly volatility is calculated as 1.27% and price to cash ratio as 17.64. AstraZeneca plc (ADR) (NYSE:AZ) showed a positive weekly performance of 2.09%.
BAE Systems PLC (ADR) (OTCMKTS:BAESY) announced it has maintained dividend coverage around the safety benchmark of 2 times forward earnings for many years now, and the company is anticipated to keep this reading steady at between 1.9 times and 2 times through to the end of 2016. BAE Systems PLC (ADR) (OTCMKTS:BAESY) on last trading day company shares ended up $28.49.